Jie Jiang et al. have pinpointed KIF20A among five key genes with elevated expression correlating to adverse outcomes in melanoma, suggesting its utility as a biomarker for diagnosis, treatment, and prognosis [28]. Here, KIF20A is linked to melanoma.